<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397590970</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164938.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199611  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/jac/38.5.799</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/jac/38.5.799</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[G. Matera, M. C. Berlinghieri, F. Foti, G. S. Barreca, A. Focà]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The way in which an antibiotic interacts with host defences could influence the clinical outcome of many infectious diseases. The impact of RO 23-9424, a novel dual-action and extended-spectrum antibiotic, was studied on several functions of human polymorphonuclear neutrophils (PMNs). A significant (P &lt; 0.05) increase of the superoxide (O2−) released by phorbol-myristate acetate (PMA) -stimulated PMN (10-100 mg/L) can be observed in the RO 23-9424 pre-treated cells. RO 23-9424, particularly at low dosages, showed an interesting but not statistically significant effect on PMN phagocytosis. Higher dosages of RO 23-9424 (50-200 mg/L) and fleroxacin (20-200 mg/L) significantly reduced PMN chemotaxis. Cytokine production by human monocytes were also evaluated after incubation with the antibiotic (100-200 mg/L) in both basal conditions and in response to endotoxin (lipopolysaccharide, LPS). In the LPS-treated cells, RO 23-9424 (100 mg/L) significantly (P &lt; 0.05) enhanced the tumour necrosis factor-α (TNF-α) levels, compared with LPS controls after 4 h of incubation. RO 23-9424 (200 mg/L) was able to reduce in a dose-dependent way LPS-induced interleukin-1β (IL-1β) after 4 and 24 h of incubation. Interleukin-8 (IL-8) release was not significantly changed by RO 23-9424. Cefotaxime (200 mg/L) significantly (P &lt; 0.05) increased the basal levels of IL-1β and reduced basal IL-8 concentration after 24 h of incubation. The lower concentration of cefotaxime reduced the LPS-stimulated IL-8 levels. Fleroxacin (100 mg/L) enhanced basal levels of IL-8. The potentiated PMN phagocytosis, the significantly enhanced O2− release by PMA-stimulated PMN and the dimetric changes of TNF-α and IL-1β appeared peculiar for RO 23-9424 and may have useful therapeutical indications.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© 1996 by the British Society for Antimicrobial Chemotherapy</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Original articles</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Matera</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Berlinghieri</subfield>
   <subfield code="D">M. C.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Foti</subfield>
   <subfield code="D">F.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Barreca</subfield>
   <subfield code="D">G. S.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Focà</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of Antimicrobial Chemotherapy</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">38/5(1996-11), 799-807</subfield>
   <subfield code="x">0305-7453</subfield>
   <subfield code="q">38:5&lt;799</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">38</subfield>
   <subfield code="o">jac</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/jac/38.5.799</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">other</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/jac/38.5.799</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Matera</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Berlinghieri</subfield>
   <subfield code="D">M. C.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Foti</subfield>
   <subfield code="D">F.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Barreca</subfield>
   <subfield code="D">G. S.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Focà</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Department of Microbiological, Neurological and Orthopaedic Sciences, Chair of Microbiology, University of Reggio Calabria, Cantanzaro, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of Antimicrobial Chemotherapy</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">38/5(1996-11), 799-807</subfield>
   <subfield code="x">0305-7453</subfield>
   <subfield code="q">38:5&lt;799</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">38</subfield>
   <subfield code="o">jac</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
